4.48
price down icon3.86%   -0.18
after-market After Hours: 4.48
loading

Terns Pharmaceuticals Inc Stock (TERN) Forecast

The Terns Pharmaceuticals Inc (TERN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.5964, representing a -42.04% decrease from the current price of $4.48. The highest analyst price target is $3.0283, and the lowest is $2.1645.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TERN Price Target
Average 4.9635 (+10.79% Upside)
loading

Is Terns Pharmaceuticals Inc (TERN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 40.22 Neutral
STOCH(9,6) 60.02 Neutral
STOCHRSI(14) 78.03 Neutral
MACD(12,26) -0.2797 Buy
ADX(14) 32.95 Sell
William %R -51.56 Neutral
CCI(14) 11.36 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
4.4955
Sell
4.5506
Sell
MA20
4.5578
Sell
4.7173
Sell
MA50
5.5082
Sell
5.3669
Sell
MA100
6.5615
Sell
6.0482
Sell
MA200
6.8759
Sell
6.3806
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, TERN could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on TERN, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 40.22 indicates that TERN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 60.02 indicates that TERN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.03 indicates that TERN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.95 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 11.36 indicates that TERN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term TERN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Terns Pharmaceuticals Inc financial reports and earnings history, Terns Pharmaceuticals Inc (TERN) stock could reach $10.69 by 2030, $46.66 by 2040 and $21.78 by 2050. See the projected annual prices until 2050 of the Terns Pharmaceuticals Inc stock below:

  • Terns Pharmaceuticals Inc (TERN) is expected to reach an average price of $8.2495 in 2035, with a high prediction of $8.0019 and a low estimate of $8.1543. This indicates an $84.14% rise from the last recorded price of $4.48.
  • Terns Pharmaceuticals Inc (TERN) stock is projected to chart a bullish course in 2040, with an average price target of $46.28, representing an $933.03% surge from its current level. The forecast ranges from a conservative $46.58 to a sky-high $46.66.
  • Our analysts predict Terns Pharmaceuticals Inc (TERN) to jump 626.57% by 2045, soaring from $33.17 to an average price of $32.55, potentially reaching $32.89. While $33.17 is the low estimate, the potential upside is significant.
  • Terns Pharmaceuticals Inc (TERN) stock is expected to climb by 2050, reaching an average of $21.21, a $373.36% jump from its current level. However, a wide range of estimates exists, with high and low targets of $21.78 and $21.36, respectively, highlighting the market's uncertainty.

Terns Pharmaceuticals Inc Stock (TERN) Year by Year Forecast

Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2025

Terns Pharmaceuticals Inc Stock (TERN) is expected to reach an average price of $4.3178 in 2025, with a high prediction of $7.7626 and a low estimate of $0.8731. This indicates an -3.62% fall from the last recorded price of $4.48.
Month Average Low High Change from today's price
March, 2025 $3.2183 $2.1645 $3.0283 -28.16%
April, 2025 $3.4547 $4.5996 $4.1721 -22.89%
May, 2025 $5.0097 $4.6759 $4.4397 +11.82%
June, 2025 $6.3048 $4.941 $5.9375 +40.73%
July, 2025 $6.8211 $6.8073 $6.5248 +52.26%
August, 2025 $7.0862 $6.8584 $6.7024 +58.17%
September, 2025 $7.9313 $7.1475 $7.7513 +77.04%
October, 2025 $7.4876 $7.6576 $7.7626 +67.13%
November, 2025 $6.5827 $7.0127 $7.0402 +46.94%
December, 2025 $6.689 $6.504 $6.439 +49.31%

Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2026

The predicted value for Terns Pharmaceuticals Inc (TERN) in 2026 is set at an average of $3.6914. Estimates vary from a peak of $7.3199 to a trough of $0.0629, indicating an -17.60% surge from the present price of $4.48.
Month Average Low High Change from today's price
January, 2026 $4.1141 $4.6591 $6.5803 -8.17%
February, 2026 $2.2892 $3.3392 $4.4967 -48.90%
March, 2026 $1.4243 $2.6807 $2.3517 -68.21%
April, 2026 $3.0406 $1.134 $0.9369 -32.13%
May, 2026 $1.3857 $1.6607 $2.752 -69.07%
June, 2026 $2.5793 $0.4195 $2.6493 -42.43%
July, 2026 $1.7129 $0.0629 $3.118 -61.77%
August, 2026 $3.3478 $1.4217 $4.2291 -25.27%
September, 2026 $2.0015 $1.6465 $3.824 -55.32%
October, 2026 $6.5264 $2.0302 $7.3199 +45.68%
November, 2026 $3.5614 $3.1914 $6.9326 -20.51%
December, 2026 $4.635 $3.6101 $6.6349 +3.46%

Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Terns Pharmaceuticals Inc (TERN) is $3.467, with a high forecast of $6.7938 and a low forecast of $0.1403. This indicates an -22.61% decrease from the last price of $4.48.
Month Average Low High Change from today's price
January, 2027 $2.06 $0.7225 $6.7938 -54.02%
February, 2027 $0.8249 $0.6224 $2.4187 -81.59%
March, 2027 $0.2815 $0.2764 $1.6536 -93.72%
April, 2027 $0.4265 $0.534 $0.096 -90.48%
May, 2027 $0.2116 $0.1403 $0.54 -95.28%
June, 2027 $1.0979 $0.2129 $0.9667 -75.49%
July, 2027 $1.527 $0.6698 $2.3383 -65.92%
August, 2027 $1.2319 $1.1019 $2.5819 -72.50%
September, 2027 $2.4656 $0.2706 $3.1056 -44.96%
October, 2027 $3.1205 $2.0944 $4.0895 -30.35%
November, 2027 $2.5654 $1.6967 $4.5392 -42.74%
December, 2027 $1.2991 $0.4716 $3.4042 -71.00%

Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2028

In 2028, Terns Pharmaceuticals Inc (TERN) is projected to reach an average price of $8.0643, with a high projection of $15.00 and a low estimate of $1.1327. This indicates an +80.01% rise from the last price of $4.48.
Month Average Low High Change from today's price
January, 2028 $3.1751 $1.2078 $4.0725 -29.13%
February, 2028 $5.2752 $1.1327 $2.8273 +17.75%
March, 2028 $6.0179 $5.3853 $4.0429 +34.33%
April, 2028 $8.638 $6.7404 $7.6375 +92.81%
May, 2028 $10.63 $8.9256 $8.5407 +137.29%
June, 2028 $14.64 $11.95 $13.17 +226.80%
July, 2028 $12.48 $14.12 $15.00 +178.59%
August, 2028 $11.68 $10.92 $11.21 +160.80%
September, 2028 $11.63 $12.15 $11.62 +159.68%
October, 2028 $12.52 $12.09 $12.46 +179.55%
November, 2028 $13.99 $12.64 $13.80 +212.20%
December, 2028 $14.73 $15.32 $14.79 +228.72%

Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2029

The 2029 price forecast for Terns Pharmaceuticals Inc Stock (TERN) is $13.21 on average, with a high prediction of $17.25 and a low estimate of $9.1734. This represents an +194.93% increase from the previous price of $4.48.
Month Average Low High Change from today's price
January, 2029 $15.34 $15.14 $14.77 +242.40%
February, 2029 $16.44 $15.22 $16.07 +266.96%
March, 2029 $16.77 $16.81 $16.48 +274.33%
April, 2029 $16.49 $16.60 $16.54 +268.08%
May, 2029 $17.43 $16.79 $17.25 +289.12%
June, 2029 $16.88 $16.99 $17.22 +276.85%
July, 2029 $15.95 $16.37 $16.73 +256.09%
August, 2029 $15.49 $15.47 $15.65 +245.66%
September, 2029 $12.81 $14.44 $15.35 +185.84%
October, 2029 $10.72 $11.77 $13.02 +139.25%
November, 2029 $9.6585 $10.96 $10.68 +115.59%
December, 2029 $8.9087 $9.1734 $9.0737 +98.85%

Terns Pharmaceuticals Inc Stock (TERN) Price Forecast for 2030

Terns Pharmaceuticals Inc Stock (TERN) is expected to reach an average price of $5.6943 in 2030, with a high forecast of $10.69 and a low forecast of $0.6947. This signifies an +27.10% surge from the last price of $4.48.
Month Average Low High Change from today's price
January, 2030 $9.1813 $9.4563 $10.69 +104.94%
February, 2030 $5.0215 $6.9015 $8.9624 +12.09%
March, 2030 $6.9016 $6.8591 $5.7627 +54.05%
April, 2030 $3.8218 $5.1942 $5.5242 -14.69%
May, 2030 $3.8444 $4.2594 $3.5744 -14.19%
June, 2030 $2.0346 $2.2096 $3.417 -54.59%
July, 2030 $2.9673 $0.6947 $0.5964 -33.77%
August, 2030 $0.6574 $1.2274 $1.4923 -85.33%
September, 2030 $4.0576 $1.94 $3.5276 -9.43%
October, 2030 $5.0702 $4.3301 $4.5877 +13.17%
November, 2030 $6.1304 $6.1228 $5.6978 +36.84%
December, 2030 $5.8405 $6.0229 $5.9129 +30.37%
$74.13
price down icon 1.09%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Cap:     |  Volume (24h):